Clinical Trials
- Colorectal Cancer
Phase II/III Study of Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy in Patients With Stage IIA Colon Cancer (COBRA)
- Digestive System
Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode (ECLIPSE)
- Ages60 years - 84 years
- GenderBoth
- Women's Health
The EMPOWER Study: Endometriosis Diagnosis Using microRNA (EMPOWER)
- Ages18 years - 49 years
- GenderFemale only
- Gynecological Cancers
A Phase II Evaluation of Afatinib
- Ages18 years and younger
- GenderFemale only
- Gynecological Cancers
A Phase 1 Open-Label, Safety, Pharmacokinetic and Preliminary Efficacy Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody-Drug Conjugate (ADC), in Patients With Advanced Epithelial Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) and Endometrial Cancers
- GenderFemale only
- Lung Cancer
A Phase II Study of AMG 510 in Participants With Previously Treated Stage IV or Recurrent KRAS G12C Mutated Non-Squamous Non-Small Cell Lung Cancer (ECOG-ACRIN LUNG-MAP SUB-STUDY)
- Digestive System
Blood and Stool Sample Collection in Subjects with a Diagnosis of Colorectal Cancer or Colorectal Lesion 2018-07 Act Fast
- Ages40 years and older
- GenderBoth
- Colorectal Cancer
Phase II Pilot Study of FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-type, Left-sided Colorectal Cancer
- Gynecological Cancers
A Phase 2 Study of VS-6766 (Dual RAF/MEK Inhibitor) Alone and In Combination With Defactinib (FAK Inhibitor) in Recurrent Low-Grade Serous Ovarian Cancer (LGSOC)
- GenderFemale only
- Addictive Behavior, Mental Health & Behavioral Research, Tobacco Addiction
Switching to Potential Reduced Exposure Products in Adult Smokers (JUUL)
- Ages21 years - 77 years
- GenderBoth